To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Health: Technology
Tuesday 26th March 2024

Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use.

Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)

In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.

In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.


Non-Departmental Publication (Guidance and Regulation)
Defence Science and Technology Laboratory

Mar. 21 2024

Source Page: Access Dstl's published research
Document: complete list of published research (ODS)

Found: Journal Article https://doi.org/10.3390/v14092057 Presymptomatic diagnosis of postoperative infection and sepsis


Select Committee
Roundtable transcript, Group 3, 30.01.24
PSN0033 - Expert Panel: Evaluation of Government’s progress on meeting patient safety recommendations

Written Evidence Mar. 19 2024

Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: My child also died of sepsis, not so long ago, just showing that very little has been learnt.


Deposited Papers
Department of Health and Social Care

Mar. 15 2024

Source Page: I. Equity in medical devices: Independent Review. Incl. appendices [Chair, Dame Margaret Whitehead]. 130p. II. Government response to the report of the equity in medical devices: independent review. 64p.
Document: IR_Equity_in_Medical_Devices_Report.pdf (PDF)

Found: for a patient with a condition that leads to low blood oxygen levels, such as COVID-19 pneumonia and sepsis


Written Question
Antimicrobials: Drug Resistance
Friday 15th March 2024

Asked by: Baroness Bennett of Manor Castle (Green Party - Life peer)

Question to the Foreign, Commonwealth & Development Office:

To ask His Majesty's Government what steps they are taking to ensure that their approach to tackling antimicrobial resistance across the world also works to end preventable deaths linked to unclean birth environments.

Answered by Lord Benyon - Minister of State (Foreign, Commonwealth and Development Office)

The UK's Ending Preventable Deaths campaign takes a multisectoral approach which includes tackling antimicrobial resistance, alongside strengthening health systems, sexual and reproductive health and rights, and broader determinants like nutrition, climate and water, sanitation and hygiene. Neonatal sepsis is a particular concern in the context of antimicrobial resistance and as such is where the UK will look to particularly align our work on water sanitation and hygiene, with our work on antimicrobial resistance and the health of mothers and newborns.


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023
Document: FOI 23/351 - attachment 1 (PDF)

Found: septic granulomatosis, Intestinal sepsis, Klebsiella sepsis, Listeria sepsis, Meningococcal sepsis,


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 27 March 2023
Document: FOI 23/188 - attachment (PDF)

Found: values before and during the event Risk factors: alcohol use, exposure to contrast media, infection/sepsis


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 19 June 2023
Document: FOI 23/403 - attachment 1 (PDF)

Found: Bacterial infections NEC Arthritis bacterial 2 0 Bacterial infection 1 0 Bacterial sepsis


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: Other infect ions were sepsis (28), pneumonia (49), influenza (5), lower respiratory tract infect ion


Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/879 - attachment 2 (PDF)

Found: Bacterial infections NEC Administration site cellulitis 1 0 Cellulitis 95 0 Citrobacter sepsis